JP2005527204A - 脂質消化率を改善するための方法および食餌組成物 - Google Patents
脂質消化率を改善するための方法および食餌組成物 Download PDFInfo
- Publication number
- JP2005527204A JP2005527204A JP2003581599A JP2003581599A JP2005527204A JP 2005527204 A JP2005527204 A JP 2005527204A JP 2003581599 A JP2003581599 A JP 2003581599A JP 2003581599 A JP2003581599 A JP 2003581599A JP 2005527204 A JP2005527204 A JP 2005527204A
- Authority
- JP
- Japan
- Prior art keywords
- function promoter
- regimen
- pet
- improved
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 38
- 235000019621 digestibility Nutrition 0.000 title claims description 37
- 235000007882 dietary composition Nutrition 0.000 title description 3
- 235000005911 diet Nutrition 0.000 claims abstract description 55
- 230000037213 diet Effects 0.000 claims abstract description 53
- 239000000203 mixture Substances 0.000 claims abstract description 51
- 230000008901 benefit Effects 0.000 claims abstract description 34
- 230000006870 function Effects 0.000 claims abstract description 29
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 28
- 210000004347 intestinal mucosa Anatomy 0.000 claims abstract description 25
- 230000003908 liver function Effects 0.000 claims abstract description 24
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 24
- 230000004203 pancreatic function Effects 0.000 claims abstract description 22
- 108010024636 Glutathione Proteins 0.000 claims abstract description 14
- 229960003180 glutathione Drugs 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 229960003080 taurine Drugs 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- 230000001737 promoting effect Effects 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims description 31
- 238000010521 absorption reaction Methods 0.000 claims description 27
- 235000019197 fats Nutrition 0.000 claims description 25
- 241001465754 Metazoa Species 0.000 claims description 21
- 230000000968 intestinal effect Effects 0.000 claims description 20
- 235000015097 nutrients Nutrition 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 235000012054 meals Nutrition 0.000 claims description 17
- 230000032683 aging Effects 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 14
- 239000006041 probiotic Substances 0.000 claims description 13
- 230000000529 probiotic effect Effects 0.000 claims description 13
- 235000018291 probiotics Nutrition 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 235000003969 glutathione Nutrition 0.000 claims description 12
- 235000016709 nutrition Nutrition 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000000194 fatty acid Substances 0.000 claims description 10
- 229930195729 fatty acid Natural products 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 9
- 102000004882 Lipase Human genes 0.000 claims description 9
- 230000002550 fecal effect Effects 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 8
- 230000003871 intestinal function Effects 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 235000013406 prebiotics Nutrition 0.000 claims description 8
- 239000013589 supplement Substances 0.000 claims description 8
- 239000002535 acidifier Substances 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 239000003002 pH adjusting agent Substances 0.000 claims description 7
- 239000004367 Lipase Substances 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 108010046377 Whey Proteins Proteins 0.000 claims description 6
- 235000019421 lipase Nutrition 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 102000010445 Lactoferrin Human genes 0.000 claims description 4
- 108010063045 Lactoferrin Proteins 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 206010071061 Small intestinal bacterial overgrowth Diseases 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 230000003636 fecal output Effects 0.000 claims description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 4
- 229940078795 lactoferrin Drugs 0.000 claims description 4
- 235000021242 lactoferrin Nutrition 0.000 claims description 4
- 210000003205 muscle Anatomy 0.000 claims description 4
- 230000007142 small intestinal bacterial overgrowth Effects 0.000 claims description 4
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 238000001784 detoxification Methods 0.000 claims description 3
- 206010016766 flatulence Diseases 0.000 claims description 3
- 235000012041 food component Nutrition 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 3
- 244000005709 gut microbiome Species 0.000 claims description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 3
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical group C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 2
- 210000002249 digestive system Anatomy 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims description 2
- 235000013410 fast food Nutrition 0.000 claims description 2
- 230000003113 alkalizing effect Effects 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 238000001723 curing Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 2
- 241000282326 Felis catus Species 0.000 description 37
- 239000003925 fat Substances 0.000 description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- 235000013372 meat Nutrition 0.000 description 13
- 235000013882 gravy Nutrition 0.000 description 11
- 241000186660 Lactobacillus Species 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- 229940039696 lactobacillus Drugs 0.000 description 10
- 235000019165 vitamin E Nutrition 0.000 description 10
- 239000011709 vitamin E Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000020774 essential nutrients Nutrition 0.000 description 8
- 210000003608 fece Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229930003427 Vitamin E Natural products 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 235000019620 fat digestibility Nutrition 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 229940046009 vitamin E Drugs 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 235000021055 solid food Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000010411 cooking Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 201000007089 exocrine pancreatic insufficiency Diseases 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 244000298479 Cichorium intybus Species 0.000 description 3
- 235000007542 Cichorium intybus Nutrition 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- 206010025476 Malabsorption Diseases 0.000 description 3
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000007407 health benefit Effects 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 235000004213 low-fat Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000035467 Pancreatic insufficiency Diseases 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 241000202221 Weissella Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- -1 alkalanizers Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000021196 dietary intervention Nutrition 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940040461 lipase Drugs 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 238000001248 thermal gelation Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000193798 Aerococcus Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001468189 Melissococcus Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000202223 Oenococcus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191965 Staphylococcus carnosus Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 235000020779 micronutrient status Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
本発明は脂質および脂質断片の有効な同化に関連した利益を与えるための組成物、およびその組成物を含有している製品を提供する。それはまた、脂質または脂質断片を有効に同化するためのそしてそれによる利益を誘発できるようにするための愛玩動物の能力を改善または維持する方法を提供する。
老化の徴候の発症の遅延;
年齢に関係した影響の軽減(amelioration);
改善された視力;
老ペットにおける消化器系の回復された機能性;および
延びた寿命
のいずれか一つ以上の中に観察可能であってもよい。
代替の態様においては、組成物は湿潤ペットフードミールの形態にある。
改善された体調(body condition);
改善された筋肉の調子(muscle tone);
改善された皮膚(skin)および毛(coat)の状態;および
より若い容姿
のいずれか一つ以上の中に観察可能である。
上昇した、栄養素およびエネルギーの消化率;
改善された腸内微生物叢(gut microflora)、たとえば、小腸内細菌の異常増殖の減少に観察されるような;
改善された糞の堅さおよび/または臭い;
最適化された糞体積;
食べ物の移動時間の改善された規則性;
低下した鼓腸(flatulence);
向上した腸解毒(gut detoxification);および
脂溶性栄養素の改善された吸収
のいずれか一つ以上の中に観察可能である。
脂肪乳化剤/乳化システムと、次のもののいずれか:
酸性化剤、または
脂肪輸送剤(リコペンのためのキャリヤーとしてのホエータンパク質)、または
それらの組合せ。
ペットにおいては、脂質の吸収は他の必須栄養素たとえばビタミンEの吸収に大いに関係しているということが判明した。従って、低い消化率を有するペットはその健康を危うくすることのある欠乏した栄養状態または最適未満の栄養状態になりやすい。
上昇した、栄養素およびエネルギーの消化率;
改善された腸微生物叢、たとえば、小腸内細菌異常増殖(「SIBO」)の減少に証明されるような;
改善された糞の堅さおよび/または臭い;
最適化された糞体積;
低下した鼓腸;
改善された腸解毒;および
食べ物の移動時間の改善された規則性
を包含する:
改善された体調および筋肉の調子;
脂肪酸やビタミンのような必須栄養素の生体内利用効率(bioavailability)を改善することによってもたらされた、改善された皮膚および毛の状態;および
より若く見えることによる、高齢ペットの総合的外観の改善
を包含してもよい。
老化の徴候の発症の遅延;
加齢の影響の軽減または改善;
老ペットにおける消化器系の機能の回復;および
延びた寿命
を包含してもよい。
改善されたフィジカルアクティビティ(physical activity);
増大したじゃれつき(playfulness)レベル;
改善された敏捷性(alertness)、メンタルパフォーマンス(mental performance)および認識力(cognitive ability);および
ペットの増大したアクティビティとじゃれつきを通しての改善されたペットと飼主の相互作用および結びつき
を包含してもよい。
改善された、水の代謝回転(water turnover);
改善された、栄養及び総合健康状態(nutritional and overall health status);
ビタミン(たとえばビタミンE)吸収を増進させることによる改善された酸化防止体質(antioxidant status);
改善された窒素平衡(nitrogen balance);
全ての脂質可溶性栄養素たとえば脂肪酸、ビタミンA、D、EおよびK、の改善された吸収;
タンパク分解(proteolysis)の低下による低減された腎臓の過剰負荷(renal overload);および
脂肪または抗酸化物質の改善された吸収に直接的または間接的に関連づけられる改善された機能
を包含する。
多数の可能性のあるものの中でもどの栄養の介在が、対照キャットフード食餌に添加されたときに、低い脂肪消化率(すなわち、80%未満)のために予め選ばれたネコの脂肪消化率を改善するかを精査するために、一連の消化率試験が使用される。
全ての参加しているネコは成年であって健康良好であり、そして妊娠していない。
各試験食餌はネコのための唯一の栄養源である。
水はいつでもネコに入手可能である。
各ネコの体重は試験の開始前に記録される。
各ネコはその代謝可能エネルギー要求をまかなうのに必要な量の食物を支給される。
ネコは5日間の糞回収前期間にわたって同じ対照食餌を支給される。
ネコの体重は6日目に記録される。
糞回収期間は6日目から15日目までである。この期間に消費された食物が記録される。
6日目に、食餌と一緒に、マーカーとして赤色酸化鉄が、缶詰食餌についてはミール質量1kg当り1.0gそして乾燥食餌についてはミール質量1kg当り2.5gの濃度で、支給される。
赤いマーク糞は回収されるべき最初のものである。赤いマーク糞が最初に出現するまでは、6日目と7日目におけるマークされてない糞(通常の色の)は捨てる。全ての赤いマーク糞ばかりでなく、最初の赤い糞が観察された後の全てのマークされてない糞が回収される。
各ネコについて回収された糞を−20℃で冷凍する。
15日目の朝に、赤い酸化鉄が再び(6日目のように)食餌に添加され、今回は試験支給期間の最後をマークするためであり、そして各ネコの体重が記録される。糞は赤いマーカーが再出現するまで回収され続ける。
食餌の2サンプルと、各ネコの糞サンプルは冷凍乾燥され、そしてタンパク質、脂肪、ドライマター、および灰分の分析のために送られる。
この実施例では、参加しているネコはエマルジョンミート食餌を受理し、その食餌は、重量%基準で、約9%の脂肪と、2.2%の灰分と、8.4%のタンパク質と、76%の水分という組成を有している。これは食餌Aと呼ばれる。
膵機能促進剤:0.1%酸性化剤(クエン酸)
肝機能促進剤:湿潤キャットフード向けには、AAFCO最小値の約4倍のレベルのタウリン(ドライマター基準で0.8重量%)
腸粘膜機能促進剤:魚油(3%)
この実施例は、重量%基準で、約31%のタンパク質と、15%の脂肪と、4.5%の繊維と、12%の水分と、5%の灰分という組成を有する通常のドライキャットフード、食餌Cと呼ぶ、を使用している。
膵機能促進剤:タウリン(0.27%)
肝機能促進剤:大豆からのレシチン(1%)
腸粘膜機能促進剤:チコリ(1%)
Claims (28)
- ペットに脂質または脂質断片の有効な同化に関する利点を与える方法であって、ペットに、それの規則的な食餌として又はそれに加えて、膵機能促進剤と、肝機能促進剤および腸粘膜機能促進剤の一つまたはそれ以上とを含む食用組成物を投与する工程を含んでいる、前記方法。
- 膵機能促進剤がリパーゼ、腸pH調節剤または膵臓エキスを含む、請求項1の方法。
- 肝機能促進剤が、タウリン、乳化剤、ビタミン、ミネラル、グルタチオンおよびグルタチオン促進剤、およびそれらの組合せから選ばれる、請求項1または2の方法。
- 腸粘膜機能促進剤が脂肪輸送用の助剤、作用物質またはキャリヤーを含む、先行請求項のいずれか一項の方法。
- ペットの利点が、腸機能、外見、ペットと飼主の関係、加齢および一般健康面の少なくとも一つに関している、先行請求項のいずれか一項の方法。
- 利点が加齢に関しており、そして
老化の徴候の発症の遅延、
年齢に関係した影響の軽減、
改善された視力、
老ペットにおける消化器系の回復された機能性、および
延びた寿命
のいずれか一つまたはそれ以上の中に観察可能である、請求項5の方法。 - 組成物が、栄養的にバランスのとれたそのまま食せるミールの形態にある、先行請求項のいずれか一項の方法。
- 組成物が乾燥キブルを含む、請求項7の方法。
- 組成物がミールサプリメントとして投与される、先行請求項のいずれか一項の方法。
- 利点が外見に関しており、そして
改善された体調、
改善された筋肉の調子、
改善された皮膚および毛の状態、および
より若い容姿
のいずれか一つまたはそれ以上の中に観測可能である、請求項5〜9のいずれか一項の方法。 - 脂質消化率を維持、改善、促進またはそうでなくても向上させるための栄養管理養生法であって、愛玩動物に、予め定められた指示に従って、有効な脂質同化促進量で規則的に支給するための食餌構成要素を含んでおり、この食餌構成要素が膵機能促進剤と、肝機能促進剤および腸粘膜機能促進剤のいずれか一つまたはそれ以上とを含む、前記養生法。
- 膵機能促進剤がリパーゼ、腸pH調節剤または膵臓エキスを含む、請求項11の養生法。
- pH調節剤が、酸性化剤、アルカリ化剤、緩衝剤、プレバイオティックまたはプロバイオティック微生物の一つまたはそれ以上を包含する、請求項12の養生法。
- 肝機能促進剤が、タウリン、乳化剤、ビタミン、ミネラル、グルタチオンおよびグルタチオン促進剤、およびそれらの組合せから選ばれる、請求項11から13のいずれか一項の養生法。
- 肝機能促進剤が、摂取後に内在性グルタチオンを増加させる栄養素である、請求項11〜14のいずれか一項の養生法。
- 腸粘膜機能促進剤が脂肪輸送用の助剤、作用物質またはキャリヤーを包含する、請求項11〜15のいずれか一項の養生法。
- 助剤、作用物質またはキャリヤーが、ホエータンパク質、およびリポタンパク質の形成を促進する能力を有するプロテアーゼから選ばれる、請求項16の養生法。
- 腸粘膜機能促進剤が、抗炎症剤、ラクトフェリン、プレバイオティックまたはプロバイオティック微生物を包含する、請求項16または17の養生法。
- 抗炎症剤がω−3−脂肪酸である、請求項18の養生法。
- 脂肪輸送用の助剤、作用物質またはキャリヤーが、脂質吸収を改善するように選ばれた脂肪酸プロフィルを有する、請求18または19の養生法。
- 脂肪酸プロフィルが多価不飽和性である、請求項20の養生法。
- 脂肪輸送用の助剤、作用物質またはキャリヤーがホエータンパク質を含む、請求項21の養生法。
- ペットによって脂質または脂質断片の有効な同化作用から誘発可能な利点が、腸機能、外見、ペットと飼主の関係、加齢および一般健康面の少なくとも一つに関する、請求項11〜22のいずれか一項の養生法。
- 腸機能に関する利点が、
上昇した、栄養素およびエネルギーの消化率;
改善された腸微生物叢、たとえば、小腸内細菌異常増殖の減少に観察されるような;
改善された糞の堅さおよび/または臭い;
最適化された糞体積;
食べ物の移動時間の改善された規則性;
低下した鼓腸;
向上した腸解毒;および
脂溶性栄養素の改善された吸収
のいずれか一つまたはそれ以上の中に観察可能である、請求項23の養生法。 - 外見に関する利点が、
改善された体調;
改善された筋肉の調子;
改善された皮膚および毛の状態;および
より若い容姿
のいずれか一つまたはそれ以上の中に観察可能である、請求項23の養生法。 - 愛玩動物への、予め定められた指示に従っての、規則的投与によって、愛玩動物における脂質消化率を維持、改善、促進またはそうでなくても向上させるのに使用するための食用組成物であって、膵機能促進剤と、肝機能促進剤および腸粘膜機能促進剤のいずれか一つまたはそれ以上とを含む、前記組成物。
- 愛玩動物の外観を改善する方法であって、膵機能促進剤と、肝機能促進剤、腸粘膜機能促進剤またはそれらの組合せとを含有している食餌をペットに支給することによって、ペットの、それの食餌の中の脂肪を消化する能力を増進させる工程を含んでいる、前記方法。
- 膵機能促進剤が脂肪乳化剤/乳化システムを含み、腸粘膜機能促進剤が酸性化剤を含み、そして腸粘膜機能促進剤が脂肪輸送用作用物質を含む、請求項27の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02076346A EP1350435B1 (en) | 2002-04-05 | 2002-04-05 | Compositions and methods for promoting lipid assimilation in pets |
PCT/EP2003/003520 WO2003084342A2 (en) | 2002-04-05 | 2003-04-03 | Method and dietary composition for improving lipid digestibility |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008313528A Division JP2009114196A (ja) | 2002-04-05 | 2008-12-09 | 脂質消化率を改善するための方法および食餌組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005527204A true JP2005527204A (ja) | 2005-09-15 |
Family
ID=27838118
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003581600A Pending JP2005521415A (ja) | 2002-04-05 | 2003-04-03 | 脂質消化率を改善するための方法および食餌組成物 |
JP2003581601A Pending JP2006511192A (ja) | 2002-04-05 | 2003-04-03 | ペット動物によるビタミンeの吸収の改良方法 |
JP2003581599A Pending JP2005527204A (ja) | 2002-04-05 | 2003-04-03 | 脂質消化率を改善するための方法および食餌組成物 |
JP2008313520A Pending JP2009082142A (ja) | 2002-04-05 | 2008-12-09 | ペット動物によるビタミンeの吸収の改良方法 |
JP2008313528A Pending JP2009114196A (ja) | 2002-04-05 | 2008-12-09 | 脂質消化率を改善するための方法および食餌組成物 |
JP2008313593A Pending JP2009142277A (ja) | 2002-04-05 | 2008-12-09 | 脂質消化率を改善するための方法および食餌組成物 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003581600A Pending JP2005521415A (ja) | 2002-04-05 | 2003-04-03 | 脂質消化率を改善するための方法および食餌組成物 |
JP2003581601A Pending JP2006511192A (ja) | 2002-04-05 | 2003-04-03 | ペット動物によるビタミンeの吸収の改良方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008313520A Pending JP2009082142A (ja) | 2002-04-05 | 2008-12-09 | ペット動物によるビタミンeの吸収の改良方法 |
JP2008313528A Pending JP2009114196A (ja) | 2002-04-05 | 2008-12-09 | 脂質消化率を改善するための方法および食餌組成物 |
JP2008313593A Pending JP2009142277A (ja) | 2002-04-05 | 2008-12-09 | 脂質消化率を改善するための方法および食餌組成物 |
Country Status (14)
Country | Link |
---|---|
US (4) | US8475834B2 (ja) |
EP (5) | EP1350435B1 (ja) |
JP (6) | JP2005521415A (ja) |
CN (3) | CN1652696B (ja) |
AT (1) | ATE492166T1 (ja) |
AU (3) | AU2003224038B2 (ja) |
BR (4) | BRPI0309005B1 (ja) |
CA (3) | CA2480446A1 (ja) |
DE (1) | DE60238663D1 (ja) |
ES (5) | ES2355890T3 (ja) |
MX (3) | MXPA04009741A (ja) |
RU (3) | RU2324365C2 (ja) |
WO (3) | WO2003084343A2 (ja) |
ZA (3) | ZA200408956B (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010284087A (ja) * | 2009-06-09 | 2010-12-24 | Noji Kumiai Hojin Factor | 鶏卵、鶏卵の生産方法および改良方法、ならびに採卵鶏用飼料 |
JP2012514457A (ja) * | 2009-01-06 | 2012-06-28 | ネステク ソシエテ アノニム | チャンクゼリー食品組成物 |
US9724296B2 (en) | 2008-10-08 | 2017-08-08 | Vitux Group As | Chewable gelled emulsions |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921422B2 (en) | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
US20050118234A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Methods and kits related to administration of a fructooligosaccharide |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
ES2304585T3 (es) * | 2004-09-21 | 2008-10-16 | Nestec S.A. | Longevidad mejorada de gatos de avanzada edad. |
EP1830629A4 (en) * | 2004-12-30 | 2008-08-27 | Hills Pet Nutrition Inc | METHODS FOR ENHANCING THE QUALITY OF LIFE OF AN ANIMAL AGE |
US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
DK1838169T3 (en) | 2004-12-30 | 2016-08-15 | Hills Pet Nutrition Inc | Methods for improving the quality of life of a growing animal |
WO2006130188A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic bifidobacteria |
DK1880001T3 (da) | 2005-05-31 | 2011-09-12 | Iams Company | Feline probiotiske lactobacilli |
US20070059297A1 (en) * | 2005-08-04 | 2007-03-15 | Nestec, S.A. | Methods and compositions for improving visual acuity |
US20090136588A1 (en) * | 2005-12-02 | 2009-05-28 | Hill's Pet Nutrition, Inc. | Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency |
NZ569235A (en) * | 2005-12-15 | 2011-12-22 | Nestec Sa | Compositions and methods for preserving brain function using medium chain triglycerides |
GB0602426D0 (en) | 2006-02-07 | 2006-03-22 | Trouw Internat Bv | Feed for fish |
JP5799299B2 (ja) | 2007-02-01 | 2015-10-21 | ザ・アイムス・カンパニーThe Iams Company | ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法 |
JP5002442B2 (ja) * | 2007-12-20 | 2012-08-15 | 森永乳業株式会社 | 脂質吸収促進剤 |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
WO2009152283A1 (en) * | 2008-06-12 | 2009-12-17 | Professor Connors, Inc. | Pet food treats, pet food treats processing system, and process for making the pet food treats |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
AU2013200758B2 (en) * | 2008-07-18 | 2014-06-12 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
JP2011528556A (ja) * | 2008-07-18 | 2011-11-24 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 高齢の動物の生活の質を向上させるための方法 |
EP2328418B1 (en) * | 2008-08-26 | 2017-10-25 | Nestec S.A. | A method of reducing the enzymatic digestion rates of starch granules in food and food products produced therefrom |
ES2545739T3 (es) * | 2009-03-11 | 2015-09-15 | Nestec S.A. | Trozos en composiciones alimentarias de tipo salsa |
US8691303B2 (en) * | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
US9210945B2 (en) * | 2009-07-31 | 2015-12-15 | The Iams Company | Animal food having low water activity |
US9173423B2 (en) * | 2009-07-31 | 2015-11-03 | The Iams Company | Animal food kibble with electrostatically adhered dusting |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US20110027417A1 (en) | 2009-07-31 | 2011-02-03 | Patrick Joseph Corrigan | Process for Dusting Animal Food |
BR112012008589A2 (pt) * | 2009-10-15 | 2016-04-05 | Nestec Sa | processos para identificação de animais com uma reduzida habilidade para digerir lipídeo e proteína |
CN101874570B (zh) * | 2009-11-20 | 2012-06-20 | 天津集合科技有限公司 | 一种宠物食品的外表面喷涂营养组合物及其喷涂方法 |
US20140147427A1 (en) * | 2011-06-08 | 2014-05-29 | Organobalance Gmbh | Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
RU2520840C2 (ru) * | 2011-12-27 | 2014-06-27 | Государственное научное учреждение Всероссийский научно-исследовательский институт мясного скотоводства Российской академии сельскохозяйственных наук | Комплексный пробиотический препарат для крупного рогатого скота мясных пород |
JP6267129B2 (ja) * | 2011-12-29 | 2018-01-24 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
JP2014018172A (ja) * | 2012-07-20 | 2014-02-03 | Kohjin Life Sciences Co Ltd | 過酸化脂質生成を抑制するペットフード |
JP6073481B2 (ja) * | 2012-09-13 | 2017-02-01 | スペスィアリテ、ペット、フードSpecialites Pet Food | ペットフードの増強された嗜好性を長時間維持するための脂肪組成物の使用 |
KR101292518B1 (ko) | 2013-01-15 | 2013-08-07 | 조규만 | 분쇄한 식용동물 및 어류와 그 부산물에 호박과 타우린을 함유한 애완동물용 액상사료의 제조방법 |
CN105815545A (zh) * | 2015-01-06 | 2016-08-03 | 中粮集团有限公司 | 一种有机酸组合物及其应用、制剂 |
WO2016133909A1 (en) | 2015-02-16 | 2016-08-25 | Mars, Incorporated | Interlocking kibble |
AU2016255437B2 (en) | 2015-04-28 | 2020-10-08 | Mars, Incorporated | Process of preparing a sterilized wet pet food product |
US20200221734A1 (en) | 2015-09-01 | 2020-07-16 | Dupont Nutrition Biosciences Aps | Methods of increasing fat soluble vitamin uptake in feed |
KR102604237B1 (ko) * | 2016-06-02 | 2023-11-20 | (주)아모레퍼시픽 | 지용성 비타민 흡수 강화용 조성물 |
US10052282B2 (en) * | 2016-09-23 | 2018-08-21 | Sydney Baskins | Pet hydration system |
CA3027257C (en) * | 2016-12-15 | 2024-05-28 | Nestec S.A. | Compositions and methods that modulate digestibility in a companion animal |
CN116507217A (zh) * | 2020-10-21 | 2023-07-28 | 希尔氏宠物营养品公司 | 宠物食品组合物 |
CA3241068A1 (en) * | 2021-12-16 | 2023-06-22 | Dinesh SRINIVASAN | Lipase formulations and methods thereof |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2004409A1 (de) | 1970-01-31 | 1971-09-02 | Keimdiat GmbH, 8900 Augsburg | Natürlicher Wirkstoff fur pharmazeuti sehe und diätetische Zwecke |
GB1368784A (en) * | 1970-12-09 | 1974-10-02 | Astra Nutrition Ab | Foodstuffs for young animals |
FR2242935B1 (ja) * | 1973-09-07 | 1978-02-10 | Colgate Palmolive Co | |
JPS57163313A (en) | 1981-03-31 | 1982-10-07 | Nippon Shinyaku Co Ltd | Vitamin e pharmaceutical and its preparation |
EP0096902B1 (en) * | 1982-06-16 | 1988-09-28 | Taiyo Fishery Co., Ltd. | Method for the production of protein food products or protein food materials in paste state and method for the production of food products from these materials |
US4804549A (en) * | 1984-10-25 | 1989-02-14 | Gaines Pet Foods Corp. | Particulate dog food palatability enhancer and process |
US4963380A (en) | 1987-11-30 | 1990-10-16 | General Mills, Inc. | Beverages containing fish oils stabilized with fructose |
CH676470A5 (ja) | 1988-02-03 | 1991-01-31 | Nestle Sa | |
FI892006A (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Lactalbumin saosom tillaeggsaemne i mat. |
JP2677613B2 (ja) | 1988-06-24 | 1997-11-17 | エーザイ株式会社 | ビタミンe又はその誘導体の吸収促進組成物 |
US5053222A (en) | 1989-06-07 | 1991-10-01 | Shiseido Company Ltd. | Hair cosmetic composition |
DE69005255T2 (de) * | 1989-10-06 | 1994-04-07 | Franca Leo | Nahrungsmittel für Haustiere und Verfahren zu deren Herstellung. |
JPH03219839A (ja) | 1990-01-23 | 1991-09-27 | San Ei Chem Ind Ltd | ペットフードの製造法 |
JP3347381B2 (ja) | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
GB2277862A (en) | 1993-05-12 | 1994-11-16 | Nutec Ltd | A nutritional composition for oral administration to an animal |
JPH06319465A (ja) * | 1993-05-13 | 1994-11-22 | Baiotsukusu:Kk | 飼料及びその製造方法 |
DE4428852C1 (de) | 1994-08-04 | 1995-10-26 | Heike Koenig | Katzenfutterdressing |
US5976580A (en) * | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
US6015798A (en) | 1995-10-10 | 2000-01-18 | Colgate Palmolive Company | Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
US5707670A (en) | 1996-08-29 | 1998-01-13 | The Procter & Gamble Company | Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components |
US5883083A (en) | 1997-06-09 | 1999-03-16 | Harlmen, Inc. | Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines |
RU2118494C1 (ru) | 1997-06-24 | 1998-09-10 | Елена Марковна Фатеева | Пищевой продукт |
US6063414A (en) | 1997-08-18 | 2000-05-16 | Seal Rock Technologies Incorporated | Combination container and dry pet food for increased shelf life, freshness, palatability, and nutritional value |
US6013665A (en) * | 1997-12-16 | 2000-01-11 | Abbott Laboratories | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
US6369252B1 (en) * | 1998-02-26 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Structured lipids |
US6149932A (en) | 1998-03-24 | 2000-11-21 | Stabar Enterprises, Inc. | Dietary supplement for preventing or reducing shedding of hair |
US6288116B1 (en) | 1998-05-13 | 2001-09-11 | Novartis Nutrition Ag | Method of administration of a nutritional product to a person having renal failure |
CA2342846C (en) * | 1998-09-08 | 2005-12-06 | Societe Des Produits Nestle S.A. | Milk-based powder for pets |
CN1321089A (zh) | 1998-09-08 | 2001-11-07 | 比奥莫勒克拉制品公司 | 增加肠吸收脂肪的方法和组合物 |
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
US6254920B1 (en) | 1998-11-24 | 2001-07-03 | Ralston Purina Company | Methods and compositions for enhancing palatability of pet food |
CA2369623A1 (en) * | 1998-12-18 | 2000-06-29 | Neil A. Morrison | Gelatin replacement composition |
US6156354A (en) * | 1999-01-29 | 2000-12-05 | Brandeis University | Hyper-absorption of vitamin E dispersed in milks |
NZ527924A (en) † | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
GB2367489B (en) * | 2000-07-31 | 2005-02-09 | Mars Inc | Use of antioxidants |
US20030198661A1 (en) * | 2000-01-31 | 2003-10-23 | Mars Incorporated | Antioxidant compositions and methods for companion animals |
US6228418B1 (en) * | 1999-04-07 | 2001-05-08 | Cyvex Nutrition | Vegetarian pet treat |
KR20020005050A (ko) * | 1999-05-27 | 2002-01-16 | 디 아이암즈 캄파니 | 산화방지제의 배합물을 이용하여 애완 동물의 면역 반응을증강시키기 위한 방법 및 제품 |
JP2001136914A (ja) * | 1999-08-30 | 2001-05-22 | Earth Chem Corp Ltd | ペットフード |
ATE397868T1 (de) | 1999-09-07 | 2008-07-15 | Nestle Sa | Verfahren zur verbesserung der haut und des pelzes von haustieren |
BR0013879B1 (pt) | 1999-09-09 | 2013-07-23 | método não terapêutico e nutracêutico para melhorar a condição de saúde, para aumentar a longevidade ou para aumentar a qualidade de vida de um animal de estimação de idade avançada, e alimento para animal de estimação | |
US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
JP2001145464A (ja) | 1999-11-19 | 2001-05-29 | T Hasegawa Co Ltd | 家畜、家禽及びペットフード用飼料添加剤 |
US6228367B1 (en) * | 1999-12-22 | 2001-05-08 | Renew Life, Inc. | Food supplement formulation |
US6524619B2 (en) * | 2000-01-27 | 2003-02-25 | Chronorx, Inc. | Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
HU227182B1 (en) | 2000-03-06 | 2010-09-28 | Andras Javor | Lecitin-ascorbic acid combination |
US6610007B2 (en) * | 2000-04-03 | 2003-08-26 | Neoguide Systems, Inc. | Steerable segmented endoscope and method of insertion |
US6946488B2 (en) * | 2000-05-01 | 2005-09-20 | The Iams Company | Pet food composition for reducing inflammatory response in cats |
DE60127829T2 (de) * | 2000-05-01 | 2007-12-27 | The Iams Company, Dayton | Haustierfutterzusammensetzung zur verminderung der entzündungsreaktion in katzen |
JP2003534019A (ja) * | 2000-06-01 | 2003-11-18 | ユナイテッド フィーズ,インコーポレーテッド | 動物飼料および方法 |
US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
EE200300109A (et) | 2000-09-20 | 2005-04-15 | Nycomed Pharma As | Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon |
US20020119237A1 (en) * | 2000-12-22 | 2002-08-29 | Hevey Maurice O. | Medium and method for delivery of edible materials subject to degradation by oxidation and hydrolysis |
MXPA03007802A (es) * | 2001-03-09 | 2003-12-08 | Nestle Sa | Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad. |
EP1243273A1 (en) | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
AU784852B2 (en) | 2001-08-10 | 2006-07-06 | Mars, Incorporated | Canine support diet |
US6576667B2 (en) * | 2001-11-14 | 2003-06-10 | Norel Acquisition Corp. | Method for manufacturing fatty acid calcium salts from high glyceride content oils |
AU2002358036A1 (en) * | 2001-12-05 | 2003-06-17 | Dsm Ip Assets B.V. | Methods and compositions for use in pet breeding |
EP1325682A1 (en) | 2001-12-11 | 2003-07-09 | Societe Des Produits Nestle S.A. | Food or pet food composition containing plant extracts for maintenance of bone health and prevention or treatment of bone diseases |
DE60322240D1 (de) * | 2002-05-03 | 2008-08-28 | Texas A & M Univ Sys | Katzenpankreas-lipase-zusammensetzung und verfahren zur herstellung und verwendung einer solchen zusammensetzung |
EP3698780A1 (en) * | 2004-08-09 | 2020-08-26 | Enrique Melendez Hevia | Glycine as a diet supplement for use in the prevention and/or treatment of an infectious disease caused by a virus in a human in the need of promoting the synthesis of collagen |
-
2002
- 2002-04-05 DE DE60238663T patent/DE60238663D1/de not_active Expired - Lifetime
- 2002-04-05 ES ES02076346T patent/ES2355890T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP02076346A patent/EP1350435B1/en not_active Expired - Lifetime
- 2002-04-05 AT AT02076346T patent/ATE492166T1/de not_active IP Right Cessation
-
2003
- 2003-04-03 RU RU2004132217/13A patent/RU2324365C2/ru active
- 2003-04-03 US US10/509,951 patent/US8475834B2/en active Active
- 2003-04-03 RU RU2004132705/13A patent/RU2316224C2/ru active
- 2003-04-03 BR BRPI0309005A patent/BRPI0309005B1/pt active IP Right Grant
- 2003-04-03 EP EP08154598.0A patent/EP1952700B1/en not_active Revoked
- 2003-04-03 CA CA002480446A patent/CA2480446A1/en not_active Abandoned
- 2003-04-03 JP JP2003581600A patent/JP2005521415A/ja active Pending
- 2003-04-03 CA CA002480709A patent/CA2480709A1/en not_active Abandoned
- 2003-04-03 ES ES08154598.0T patent/ES2632951T3/es not_active Expired - Lifetime
- 2003-04-03 WO PCT/EP2003/003522 patent/WO2003084343A2/en active Application Filing
- 2003-04-03 MX MXPA04009741A patent/MXPA04009741A/es active IP Right Grant
- 2003-04-03 RU RU2004132706/13A patent/RU2316225C2/ru active
- 2003-04-03 MX MXPA04009765A patent/MXPA04009765A/es active IP Right Grant
- 2003-04-03 AU AU2003224038A patent/AU2003224038B2/en not_active Expired
- 2003-04-03 CA CA2480708A patent/CA2480708C/en not_active Expired - Lifetime
- 2003-04-03 EP EP03720422.9A patent/EP1492415B2/en not_active Expired - Lifetime
- 2003-04-03 BR BR0308995-9A patent/BR0308995A/pt active IP Right Grant
- 2003-04-03 CN CN03810234XA patent/CN1652696B/zh not_active Expired - Lifetime
- 2003-04-03 US US10/509,949 patent/US20060134090A1/en not_active Abandoned
- 2003-04-03 ES ES03720422T patent/ES2402091T5/es not_active Expired - Lifetime
- 2003-04-03 US US10/510,126 patent/US20050147649A1/en not_active Abandoned
- 2003-04-03 JP JP2003581601A patent/JP2006511192A/ja active Pending
- 2003-04-03 WO PCT/EP2003/003523 patent/WO2003084344A2/en active Application Filing
- 2003-04-03 EP EP03718733.3A patent/EP1492414B1/en not_active Expired - Lifetime
- 2003-04-03 ES ES03717271T patent/ES2436208T3/es not_active Expired - Lifetime
- 2003-04-03 ES ES03718733.3T patent/ES2528194T3/es not_active Expired - Lifetime
- 2003-04-03 CN CN038102382A patent/CN1652697B/zh not_active Expired - Lifetime
- 2003-04-03 BR BRPI0309003-5A patent/BRPI0309003B1/pt unknown
- 2003-04-03 JP JP2003581599A patent/JP2005527204A/ja active Pending
- 2003-04-03 EP EP03717271.5A patent/EP1492413B1/en not_active Expired - Lifetime
- 2003-04-03 WO PCT/EP2003/003520 patent/WO2003084342A2/en active Application Filing
- 2003-04-03 MX MXPA04009758A patent/MXPA04009758A/es active IP Right Grant
- 2003-04-03 BR BR0309003-5A patent/BR0309003A/pt active IP Right Grant
- 2003-04-03 AU AU2003222797A patent/AU2003222797B2/en not_active Expired
- 2003-04-03 AU AU2003221549A patent/AU2003221549C1/en not_active Expired
- 2003-04-03 CN CN038102404A patent/CN1652698B/zh not_active Expired - Lifetime
-
2004
- 2004-11-04 ZA ZA200408956A patent/ZA200408956B/en unknown
- 2004-11-04 ZA ZA200408948A patent/ZA200408948B/en unknown
- 2004-11-04 ZA ZA200408953A patent/ZA200408953B/xx unknown
-
2008
- 2008-12-09 JP JP2008313520A patent/JP2009082142A/ja active Pending
- 2008-12-09 JP JP2008313528A patent/JP2009114196A/ja active Pending
- 2008-12-09 JP JP2008313593A patent/JP2009142277A/ja active Pending
-
2013
- 2013-06-03 US US13/908,615 patent/US8962007B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9724296B2 (en) | 2008-10-08 | 2017-08-08 | Vitux Group As | Chewable gelled emulsions |
US10668013B2 (en) | 2008-10-08 | 2020-06-02 | Vitux Group As | Chewable gelled emulsions |
JP2012514457A (ja) * | 2009-01-06 | 2012-06-28 | ネステク ソシエテ アノニム | チャンクゼリー食品組成物 |
JP2010284087A (ja) * | 2009-06-09 | 2010-12-24 | Noji Kumiai Hojin Factor | 鶏卵、鶏卵の生産方法および改良方法、ならびに採卵鶏用飼料 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1492413B1 (en) | Method and dietary composition for improving lipid digestibility | |
JP2003508070A (ja) | 老齢ペットの体調の改善 | |
BRPI0308995B1 (pt) | Composition for use in improving or conservation of vitamin absorption and in a pet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050722 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20061110 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20070314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070731 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071031 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20071031 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071107 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071130 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080610 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080908 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080916 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081009 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081017 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081105 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081112 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090407 |